Advisory Board

Dr. Jagmohan S. Sidhu, M.D.

Dr. Jagmohan S. Sidhu is director and chairman of department of Pathology and Laboratory Medicine, UHS Hospitals, Johnson City, New York, USA (an affiliate of SUNY Upstate Medical University, Syracuse, New York, USA) and Clinical Professor in Upstate Medical University (State University of New York-Clinical Campus at Binghamton, New York, USA). He is also director of Hematopathology/Flow Cytometry and Pathologist, UHS Hospitals, Johnson City, New York, USA.  He was Clinical Associate Professor, Upstate Medical University (State University of New York - Clinical Campus at Binghamton, New York, USA) from 2001 to 2005 and Clinical Assistant Professor, Upstate Medical University (State University of New York - Clinical Campus at Binghamton, New York, USA) from 1995 to 2001. He was the director of Surgical Pathology and General Pathology, UHS Hospitals, Johnson City, New York, USA from 1996 to 2000. He has set up an automated Immunohistochemistry laboratory in 1996 and has been actively involved in organizing and directing various conferences, hematology/hematopathology symposia. He earned  M.D. graduate degree from Punjabi University, Patiala, India in 1978 and post graduate degree in Pathology from the same University in 1984. He is holding medical licenses from New York, California, Texas and Nevada.

Dr. Sidhu has received the Executive Certificate Program in healthcare delivery management (sponsored by Cornell University & UCLA), American Board of Pathology (AP and CP) and American Board of Pathology (hematology). He has received special certification from New York State Department of Health as Certificate of Qualification (COQ) in Cellular Immunology, cytopathology, histopathology, hematology, immunohematology, bacteriology, mycobacteriology, mycology, parasitology, diagnostic immunology, clinical chemistry, drug analysis, endocrinology, therapeutic substance monitoring, blood lead, erythrocyte protoporphyrin, blood pH and gases, and andrology.

Dr. Sidhu was nominated for “The Doctors of Excellence” and “The Docs That Are Tops” by the United Health Services Staff. He has received commendation for “Excellent Leadership Skills, and Quality of Care” and “Business Acumen and Excellent Leadership Skills. He is also recognized as “Service Hero” and “Our Star” by the Chief Executive Officer of the United Medical Associates.

 

Dr. Gurmit S. Chilana M.D.

Dr. Gurmit Singh Chilana is Executive dean and  director of clinical affairs at All Saints University of Medicine, Aruba and New Jersey, USA. For the last 22 years, Dr. Chilana is affiliated with various hospitals in USA, including Barnert Memorial Hospital in New Jersey,  and is holding various positions such as chairman of quality assurance, chairman of the department of Obstetrics and Gynecology and President of Medical staff at Barnert Memorial Hospital in New Jersey, USA. He received MD graduate degree from Government Medical College, Punjabi University, Patiala, India and MD post graduate degree in Obstetrics and Gynecology from St Louise University of Medicine, Missouri, USA.

 

Dr. Nisha Dogra, Ph.D., M.HS. - President and Chief Executive Officer

Dr. Nisha Dogra is the President and principal founder of Advanced Genomics Corporation. She brings over twenty years of experience in the areas of science and business and contributes leadership, vision and strategic planning to Advanced Genomics. She has been in the Faculty of Medicine, University of British Columbia (consistently ranks among the top ten North American Universities for its commercialization activities), Vancouver, Canada since 2001 and in the Vancouver Coastal Health Research Institute (leading tertiary/ quaternary research institute and a joint venture with UBC), Vancouver, Canada since 2002. She played concurrent roles for leading groundbreaking cutting edge Genomics research projects of Canadian Institute of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC). She has been responsible for strategy and implementation of all operations using microarray technology beginning with the start up to profitable projects. Dr. Dogra started her research career in 1989 in the Institute of Microbial Technology, Chandigarh, India (a premier leading institute of Council of Scientific and Industrial Research, India).

Dr. Dogra did her post-doctoral training in the Faculty of Medicine, University of Montreal, Quebec, Canada. She has earned her Ph.D in molecular biology from the Institute of Integrative Medicine, C.S.I.R., Jammu, India and second Masters Degree in Health Care Management from Touro University International, California, USA.

Dr. Dogra has authored over several scientific publications in international peer-reviewed journals.

She has been in the Faculty Development Program of Medical Council of Canada as defined by Royal College of Physicians and Surgeons of Canada. She is a member of Association of Microbiologists of India, Canadian Cancer Society, Canadian Heart and Stroke Foundation and American College of Healthcare Executives.

 

Dr. Kuldip Rai Jassal, M.D.

Dr. Kuldip Rai Jassal is attending Psychiatrist in Campbellton Regional Hospital, Campbellton, New Brunswick and is involved in acute inpatient, chronic care, child and adolescent psychiatry, geriatrics, consultation-liaison, emergency, and forensic psychiatry since 2008. He was Geriatric Psychiatry Fellow at University at Buffalo, The State University of New York, NY (USA) in 2006. He has completed his Psychiatry Residency from University of British Columbia, Vancouver, BC, Canada as well as from University of Buffalo, The State University of New York, USA. He is actively involved in acute inpatient, chronic care, comprehensive psychiatric emergency, child and adolescent psychiatry, geriatrics, consultation-liaison, psychotherapy, and ECT in New York, USA. He was Psychiatry Extern in St. Elizabeth’s Hospital, Washington, DC, USA and Research Assistant in Pilgrim Psychiatric Center, Brentwood, New York (USA) and Albert Einstein College of Medicine-Yeshiva Univ, Bronx, NY (USA) in 1999. He was Clinical Observer of Psychiatry in  Mt. Pleasant Mental Health Team, Vancouver, BC, Canada in1997, Clinical Observer of Family Medicine in Melville Hospital, Goose Bay, Labrador, Canada, Clinical Observer in Emergency Medicine Central Newfoundland Regional Health Center, Grand Falls-Windsor.

He earned his M.D. graduate degree in Medicine and Surgery from Government Medical College, Amritsar, India.

Dr. Jassal is a diplomat of the American Board of Psychiatry and Neurology, Inc., a member of the American Board of Medical Specialties” since 2010. He holds unrestricted License in New Brunswick in Psychiatry and is Licentiate of Medical Council of Canada Examinations.

He is a member of Professional Liaison Committee, Regional Health Authority Zone 5, New Brunswick, Canada and Regional Health Authority Zone 5 Ethics Committee, New Brunswick, Canada. He has received “Certificate of Award” for outstanding medical services in St. Elizabeth’s Hospital, Washington, DC, USA. Dr. Jassal has been actively involved in research activities including “Genetic Variation of the Human-Mu-Opioid Receptor and Susceptibility to Schizophrenia”.

 

Dr. Jan Klesken, M.D.

Dr. Jan Klesken is medical professional with 25 years experience in various fast-paced hospitals, research and family practice settings. Dr. Klesken is a Forensic Medical Examiner in Emergency Medicine in Prince Philip’s Hospital Llanalli, FME, UK since 2006. He was Clinical Surgical Associate - post cardiovascular Surgery in St. Paul’s Hospital, Vancouver, British Columbia, Canada. He was actively involved in Healthy Heart Program to assess patients, new and follow up in Healthy heart and Lipid clinic. In 1995, Dr. Klesken was General Internist, Consultant, Gastroendoscopist in General Hospital, Banska Bystrica, Slovakia and involved in research in cardiovascular diseases and intestinal disorders including Helicobacter Pylori infection. In 1990 he was working as Internist and gastroendoscopist in  Harare Central Hospital, Harare, Zimbabwe. In 1984 he was Internist involved in Trebisov Hospital, Trebisov, Slovakia. He was Physician in ST. Paul Boffa Hospital and St. Luke’s Hospital, Malta. He has also qualified Medical council of Canadian examination in 2003.

 

Dr. K.P. Singh, M.D. (Medicine) D.M. (Endocrinology) FICN

Dr. K.P. Singh is working as a Sr. Consultant Endocrinology in Fortis hospital, India for the last 8 years. Before joining this hospital, he was working as consultant specialist in Endocrinology department in P.G.I.M.E.R Chandigarh, India for 3 years. He also established the department of Endocrinology at S.V.  Institute of Medical Sciences Tirupati Andhra Pradesh, India. He is recipient of WHO International Diabetes Center award from Minneapolis 2007 and National Builders award 2007. His biography has been included in the 2008 Marquis WHO’S WHO IN WORLD and Oxford International Biographical Centre, Cambridge, U.K. He has more than two decades of experience as an Endocrinologist and published 35 articles in peer reviewed journals. He has remarkable contributions that are the first land mark studies in the world. To name a few are: growth hormone therapy in burns, chronic fluoride toxicity in children and Metformin osteoporosis link. These studies have been highlighted in the Medline and also got good International media response in BBC and USA Today.  He is a Member of American Diabetic Association (ADA), American Endocrine Society (AES), American Association of Clinical Endocrinologist (AACE) and American Society for Bone Mineral Research (ASBMR).

 

Dr. Neeloo Singh, Ph.D.

Dr. Neeloo Singh is working as Assistant Director at Central Drug Research Institute, (C.D.R.I., CSIR) Lucknow, India. The C.D.R.I.  is considered to be a pioneer research organization in the field of biomedical research where all the infrastructure and expertise are available to develop a drug right from its concept to market. Her research interests focus on infectious diseases and are centered on molecular parasitology, specifically in elucidation of drug resistance mechanisms in clinical visceral leishmanaiasis. The contribution of host genetic factors in Leishmania susceptibility in Indian populations has also been investigated by her group. A significant basic research component involves exploration of unique biochemical pathways and enzymes for identification and validation of putative drug targets and design and development of novel drug molecules.

Dr. Singh was introduced to the glamour of parasite research subsequent to earning her Ph.D in 1992. She has authored several books and scientific publications in international peer-reviewed journals. She is two times awardee from Indian Council of Medical Research. She has been at the helm of the affairs in the inception of the Leishmaniasis Research Society (India) and organization of the 4th World Congress on Leishmaniasis at Lucknow, India. Presently she is set to uncover the parasite’s DNA blueprint. She feels ‘knowing the genetic sequence of this parasite from clinical cases, opens a new door for development of better control regimens’.